Ensysce Biosciences Inc (ENSC) — Strategic Asset Allocation Index
Ensysce Biosciences Inc (ENSC) has a Strategic Asset Allocation Index of 4.3% as of December 2025. Strategic assets (PP&E of $124.13K plus long-term investments of $-) total $124.13K, measured against net assets of $2.88 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ENSC net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Ensysce Biosciences Inc Strategic Asset Allocation Index (2019–2019)
This chart shows how Ensysce Biosciences Inc's Strategic Asset Allocation Index has evolved across 1 annual periods from 2019 to 2019. As of December 2025, the index stands at 4.3%, representing strategic assets of $124.13K against net assets of $2.88 Million USD. For live market cap and overall valuation, see Ensysce Biosciences Inc (ENSC) total market value.
Annual Strategic Asset Allocation Index for Ensysce Biosciences Inc (2019–2019)
The table below presents the year-by-year Strategic Asset Allocation Index for Ensysce Biosciences Inc from 2019 to 2019, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See ENSC net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2019 | 0.0% | $351.00 | $351.00 | $- | $186.17 Million | — |